VISINE TOTALITY  MULTI SYMPTOM RELIEF- glycerin, hypromelloses, polyethylene glycol 400, tetrahydrozoline hydrochloride, and zinc sulfate liquid 
Johnson & Johnson Consumer Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Visine® Totality® Multi-Symptom Relief

Drug Facts

Active ingredientsPurpose
Glycerin 0.2%Lubricant
Hypromellose 0.36%Lubricant
Polyethylene glycol 400 1%Lubricant
Tetrahydrozoline HCl 0.05%Redness reliever
Zinc SulfateAstringent

Uses

  • for the relief of discomfort and redness of the eye due to minor eye irritations
  • relieves dryness of the eye
  • for the temporary relief of burning and irritation due to exposure to wind or sun
  • for protection against further irritation

Warnings

For external use only

Ask a doctor before use if you have narrow angle glaucoma.

When using this product

  • pupils may become enlarged temporarily
  • overuse may cause more eye redness
  • remove contact lenses before using
  • do not use if this solution changes color or becomes cloudy
  • do not touch tip of container to any surface to avoid contamination
  • replace cap after each use

Stop use and ask a doctor if

  • you feel eye pain
  • changes in vision occur
  • redness or irritation of the eye lasts
  • condition worsens or lasts more than 72 hours

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • put 1 to 2 drops in the affected eye(s) up to 4 times a daily
  • children under 6 years of age: ask a doctor

Other information

  • some users may experience a brief tingling sensation
  • store at 20° to 25°C (68° to 77°F)

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, purified water, sodium chloride, sodium citrate

Questions?

call toll-free 888-734-7648 or 215-273-8755 (collect)

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

Sterile
Visine®
TOTALITY®
Multi-Symptom
Relief

LUBRICANT / ASTRINGENT /
REDNESS RELIEVER
EYE DROPS
UP
TO
10
HOURS
COMFORT
HYDROBLEND®

Relieves
red, burning,
watery, itchy,
gritty, dry,
irritated eyes
with HYDROBLEND®
moisturizers
for up to 10 hours
of comfort

1/2 FL OZ (15mL)

Principal Display Panel - 15 mL Bottle Carton
VISINE TOTALITY   MULTI SYMPTOM RELIEF
glycerin, hypromelloses, polyethylene glycol 400, tetrahydrozoline hydrochloride, and zinc sulfate liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42002-209
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Glycerin (UNII: PDC6A3C0OX) (Glycerin - UNII:PDC6A3C0OX) Glycerin2.5 mg  in 1 mL
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) (HYPROMELLOSE, UNSPECIFIED - UNII:3NXW29V3WO) HYPROMELLOSE, UNSPECIFIED3.6 mg  in 1 mL
Polyethylene Glycol 400 (UNII: B697894SGQ) (Polyethylene Glycol 400 - UNII:B697894SGQ) Polyethylene Glycol 40011.28 mg  in 1 mL
Tetrahydrozoline Hydrochloride (UNII: 0YZT43HS7D) (Tetrahydrozoline - UNII:S9U025Y077) Tetrahydrozoline Hydrochloride0.5 mg  in 1 mL
Zinc Sulfate, Unspecified Form (UNII: 89DS0H96TB) (Zinc Cation - UNII:13S1S8SF37) Zinc Sulfate, Unspecified Form2.5 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
Benzalkonium Chloride (UNII: F5UM2KM3W7)  
Boric Acid (UNII: R57ZHV85D4)  
Edetate Disodium (UNII: 7FLD91C86K)  
Water (UNII: 059QF0KO0R)  
Sodium Chloride (UNII: 451W47IQ8X)  
Sodium Citrate, Unspecified Form (UNII: 1Q73Q2JULR)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:42002-209-051 in 1 CARTON08/23/201108/31/2021
115 mL in 1 BOTTLE; Type 4: Device Coated/Impregnated/Otherwise Combined with Drug
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34908/23/201108/31/2021
Labeler - Johnson & Johnson Consumer Inc. (002347102)

Revised: 1/2020
Document Id: 1e5d0bca-32cc-4d8d-80b4-4a3c5a6cf079
Set id: 398d19fa-36c2-4f73-90ae-fa086f5f8a98
Version: 6
Effective Time: 20200106
 
Johnson & Johnson Consumer Inc.